Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clairissa A Hansen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
The Present and Future of Yellow Fever VaccinesClairissa A Hansen, Alan D T Barrett
Infection and Drug Resistance|November 29, 2023
Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A PerspectiveClairissa A Hansen, J Erin Staples, Alan D T Barrett
Viruses|May 27, 2026
Genetic Characterization of Yellow Fever Virus Strain JSS, the Original South American StrainMadison E Lee, Clairissa A Hansen, Jill K Thompson, et al.
Emerging Microbes & Infections|December 15, 2025
Differences in Genetic Diversity between Early Isolates of Yellow Fever Virus GenotypesMadison E Lee, Clairissa A Hansen, Jill K Thompson, et al.
Vaccines|May 26, 2026
The Yellow Fever Virus Type-Specific Epitope Recognized by Monoclonal Antibody 2D12 Neutralizes Wild Type, but Not Live Attenuated 17D or French Neurotropic Vaccine StrainsClairissa A Hansen, Shawn Rast, Jill K Thompson, et al.
NPJ Vaccines|March 18, 2022
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and developmentMegan A Files, Clairissa A Hansen, Vanessa C Herrera, et al.
Vaccine|February 26, 2024
Vaccine value profile for ChikungunyaXimena Flandes, Clairissa A Hansen, Sunil Palani, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
The Present and Future of Yellow Fever VaccinesClairissa A Hansen, Alan D T Barrett
Infection and Drug Resistance|November 29, 2023
Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A PerspectiveClairissa A Hansen, J Erin Staples, Alan D T Barrett
Viruses|May 27, 2026
Genetic Characterization of Yellow Fever Virus Strain JSS, the Original South American StrainMadison E Lee, Clairissa A Hansen, Jill K Thompson, et al.
Emerging Microbes & Infections|December 15, 2025
Differences in Genetic Diversity between Early Isolates of Yellow Fever Virus GenotypesMadison E Lee, Clairissa A Hansen, Jill K Thompson, et al.
Vaccines|May 26, 2026
The Yellow Fever Virus Type-Specific Epitope Recognized by Monoclonal Antibody 2D12 Neutralizes Wild Type, but Not Live Attenuated 17D or French Neurotropic Vaccine StrainsClairissa A Hansen, Shawn Rast, Jill K Thompson, et al.
NPJ Vaccines|March 18, 2022
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and developmentMegan A Files, Clairissa A Hansen, Vanessa C Herrera, et al.
Vaccine|February 26, 2024
Vaccine value profile for ChikungunyaXimena Flandes, Clairissa A Hansen, Sunil Palani, et al.
Pageof 1